Evidence map›Paper›PMID 14600829›Full record

ArticleHuman genetics2004

Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy.

Marco Sifringer, Birgit Uhlenberg, Stefanie Lammel, Rita Hanke, Benjamin Neumann, Arpad von Moers, Ina Koch, Astrid Speer

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Marco SifringerDepartment of Neuropediatrics, Charité, Humboldt-University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Birgit Uhlenberg
Stefanie Lammel
Rita Hanke
Benjamin Neumann
Arpad von Moers
Ina Koch
Astrid Speer
Berliner Hochschule für Technik · DECharité - Universitätsmedizin Berlin · DECS Diagnostics · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While frame-shift mutations are usually found in Duchenne muscular dystrophy (DMD), in-frame mutations are associated with the less severe phenotype of Becker's muscular dystrophy. Exceptions have been reported in both directions suggesting the existence of modifying genes, which might be helpful for innovation of new therapeutic strategies. We report on the very rare case of an intrafamilially different course of DMD, with the younger brother being far less affected than the older one when compared at the same age. In this context, we constructed a subtraction library enriched for transcripts over-expressed in the patient with the milder phenotype. Twelve random clones were sequenced, followed by database analysis. Six of them, casein kinase 1 alpha 1, RAP2B, dynactin 3 light chain, core binding factor beta, myosin light polypeptide 2 and one hypothetical gene, were further analysed by real-time RT-PCR. All these genes were over-expressed 3-20 times in the less affected patient compared with the more severely affected one. Casein kinase 1 and the hypothetical gene showed even a slightly higher expression than the control. Up-regulation of myosin light polypeptide 2, one of the most sensitive markers of muscle fibre regeneration, obviously reflects the milder phenotype. Casein kinase 1, dynactin and core binding factor are supposed to be involved in cell cycle pathways. RAP is a component of the signalling network which controls fundamental cellular processes such as proliferation and differentiation. All four might be interesting candidates for a therapeutic approach to diminish progression of dystrophy in DMD.

Indexed as

Genetic MarkersPolymorphism, GeneticCasein KinasesChildDNA-Binding ProteinsDynactin ComplexGene LibraryHumansMaleMicrotubule-Associated ProteinsMuscle, SkeletalMuscular Dystrophy, DuchenneMutationMyosinsPhenotypeProtein KinasesCasein KinasesDCTN3 protein, humanDNA-Binding ProteinsDynactin ComplexGenetic MarkersMicrotubule-Associated ProteinsMyosinsProtein KinasesRAP2B protein, humanrap GTP-Binding ProteinsRNA, MessengerTranscription Factor AP-2Transcription Factors

Identifiers

PMID14600829
OpenAlexW2069167453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.